Retina

Watching out for inevitable degenerative changes can improve patient care.

The primary findings were that a higher BMI was protective against glaucoma progression and use of tobacco and alcohol were not significantly associated with retinal nerve fiber layer change.

Studies point to an inverse association between diabetes and keratoconus risk.

Dr. Carolyn Majcher's lecture on posterior uveitis reinforced the need for optometrists to be vigilant in their diagnostic approach.

AMN, a rare disease, is characterized by dark reddish, wedge-shaped macular lesions.

The company noted that new OPGx-LCA5 Phase 1/2 6-month data demonstrate safety and visual improvement in early onset retinal degeneration.

The OCS-01 eye drops, which utilize an OPTIREACH formulation of high concentration dexamethasone, are intended to be a non-invasive topical treatment.

An optometrist describes her journey as the first retina optometrist in Colorado.

A recent paper sparks concerns over inadequate screening and management, especially among Black and Hispanic youths, according to its authors.

Changes associated with Alzheimer's disease extend beyond the brain, according to a new study.

Because the inner retinal function is thought to affect the emmetropization process, study authors suggested that caffeine may be involved in ocular growth.

CVD could impact physicians' ability to identify choroidal melanoma from choroidal nevus.

Mark Dunbar, OD, FAAO, emphasizes the critical role optometrists play in the collaborative care of diabetic eye disease.

Dr. Ferrucci summarizes his Vision Expo West presentations and shares clinical pearls for managing retinal cases.

From schools for blind individuals to early intervention services, families have options to help prepare their children with visual impairments for adulthood.

By identifying progressive GA earlier, primary eye care providers can make timely referrals and save patients’ visual function.

Living a long life and preserving eye health can go hand in hand.

Researchers at the Medical College of Georgia at Augusta University are teaming up with Polaris Dawn to investigate how eye changes astronauts may experience during spaceflight could lead to multiple symptoms once back on Earth.

The product candidate is a modifier gene therapy for broad retinitis pigmentosa indication.

The device features cross-polarized light technology, allowing for image clarity without the need for pupil dilation.

Understanding the latest innovative technologies.

A research team for the $3.3 million study will assess the front and the back of the eye and different types of glucose dysfunction.

Some cases require unorthodox approaches.